Evidence map›Paper›PMID 29070819›Full record

ArticleScientific reports2017

Minocycline modulates microglia polarization in ischemia-reperfusion model of retinal degeneration and induces neuroprotection.

Amel Ahmed, Lei-Lei Wang, Safaa Abdelmaksoud, Amal Aboelgheit, Safaa Saeed, Chun-Li Zhang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Minocycline treatment reduces the activation of mononuclear phagocytes and improves retinal function in a mouse model of Leber congenital amaurosis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Regulation of microglia polarization after cerebral ischemia.Frontiers in cellular neuroscience · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Amel AhmedDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA.
Lei-Lei WangDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA.
Safaa AbdelmaksoudDepartment of Histology and Cell Biology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Amal AboelgheitDepartment of Histology and Cell Biology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Safaa SaeedDepartment of Histology and Cell Biology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Chun-Li ZhangDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA. Chun-Li.Zhang@UTSouthwestern.edu.ORCID 0000-0002-2639-4605
Assiut University · EGThe University of Texas Southwestern Medical Center · USSouthwestern Medical Center · US

Funding

Reprogramming reactive glial cells into functional new neurons after SCIR01NS111776 · NINDS · INDIANA UNIVERSITY INDIANAPOLIS · PI WU, WEI, ZHANG, CHUN-LI · 2020 to 2024
$2.4M
Induced Adult Neurogenesis for Parkinson's DiseaseR01NS092616 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI ZHANG, CHUN-LI · 2016 to 2020
$2.4M
In Vivo Reprogramming of Glial Fate for Spinal Cord RepairR01NS088095 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI ZHANG, CHUN-LI · 2014 to 2018
$1.7M
Transcriptional Control of Adult Neural Stem CellsR01NS070981 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI ZHANG, CHUN-LI · 2011 to 2015
$1.7M
Reprogramming the Human Glioma GenomeR21NS093502 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI ZHANG, CHUN-LI · 2015 to 2016
$445k
NINDS NIH HHS R01 NS070981NINDS NIH HHS R01 NS088095NINDS NIH HHS R01 NS092616NINDS NIH HHS R01 NS111776NINDS NIH HHS R21 NS093502
6 · The paper itself

Abstract

Retinal ischemia-reperfusion (IR) injury causes irreversible loss of neurons and ultimately leads to permanent visual impairment and blindness. The cellular response under this pathological retinal condition is less clear. Using genetically modified mice, we systematically examined the behavior of microglia/macrophages after injury. We show that IR leads to activation of microglia/macrophages indicated by migration and proliferation of resident microglia and recruitment of circulating monocytes. IR-induced microglia/macrophages associate with apoptotic retinal neurons. Very interestingly, neuron loss can be mitigated by minocycline treatment. Minocycline induces Il4 expression and M2 polarization of microglia/macrophages. IL4 neutralization dampens minocycline-induced M2 polarization and neuroprotection. Given a well-established safety profile as an antibiotic, our results provide a rationale for using minocycline as a therapeutic agent for treating ischemic retinal degeneration.

Indexed as

Disease Models, AnimalNeuroprotectionAnimalsAnti-Bacterial AgentsMaleMiceMice, Inbred C57BLMicrogliaMinocyclineReperfusion InjuryRetinaRetinal DegenerationAnti-Bacterial AgentsMinocycline

Identifiers

PMID29070819
PMCPMC5656679
OpenAlexW2765659701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.